Antibiotics timing coordination with imaging when unstable
C reactive protein or erythrocyte sedimentation rate for inflammatory signal
Non specific elevation in malignancy and infection
Malignancy evaluation when new diagnosis suspected
PSA in older male with bony pain
Serum protein electrophoresis with lytic lesions suspicion
Serum free light chains with myeloma suspicion
Steroid safety monitoring
Glucose monitoring after corticosteroids
Hyperglycemia risk
Electrolytes monitoring with prolonged corticosteroids
Sodium retention risk
Diagnostic Tests
Scoring Systems
Scoring and classification tools
Epidural spinal cord compression grading
Bilsky ESCC grade for degree of thecal sac and cord compression
Higher grade associated with greater neurologic risk
Mechanical instability assessment
Spinal Instability Neoplastic Score for instability risk
Pain component emphasizing mechanical pain
Prognostic stratification for treatment selection
Tokuhashi score for survival prediction in spinal metastases
Tomita score for surgical strategy selection
Functional status measures
ECOG performance status
Karnofsky performance status
MRI
MRI preferred diagnostic modality
Whole spine MRI with and without contrast
Multilevel disease frequency
Surgical and radiation planning benefit
Urgency targets
Same day imaging for neurologic deficit progression
Within 24 hours for suspected compression with symptoms
MRI findings supporting malignant compression
Epidural mass
Vertebral body metastasis
Pathologic fracture
Spinal cord edema
MRI contraindications and alternatives
Non compatible implanted device
Severe claustrophobia requiring sedation pathway
CT
CT role and limitations
CT spine for bony anatomy and instability assessment
Vertebral collapse
Posterior element involvement
CT myelography when MRI unavailable or contraindicated
Invasive procedure risk
Requires expert availability
CT limitations for soft tissue epidural disease
Lower sensitivity for early epidural tumor
Ultrasound (or US)
Ultrasound adjuncts
Bladder ultrasound for urinary retention assessment
Post void residual estimation
Catheter need support
Vascular ultrasound considerations
Deep vein thrombosis assessment in immobilized patient
POCUS limitations
No role in diagnosing epidural compression directly
Disposition
Level of care and pathway decisions
Admission requirements
Suspected or confirmed malignant spinal cord compression
Neurologic monitoring
Definitive therapy coordination
Motor deficit or sphincter dysfunction
High risk of irreversible injury
Uncontrolled pain requiring parenteral therapy
Frequent reassessment need
Higher acuity placement criteria
High cervical lesion suspicion
Respiratory monitoring
Rapidly progressing deficits
Frequent neuro checks
Post operative status
Hemodynamic monitoring
Transfer criteria
No urgent MRI capability
No spine surgery capability
No urgent radiotherapy capability
Consultant confirmation and timing
Definitive management coordination
Neurosurgery or spine surgery treatment decision
Decompression and stabilization candidacy
Radiation oncology treatment plan
Emergency radiotherapy for non surgical candidates
Oncology hematology systemic therapy planning
Radiosensitive tumor systemic control
Treatment
Corticosteroids
Steroid strategy
Dexamethasone for suspected malignant spinal cord compression with neurologic symptoms
Initial dosing typical regimen
16 mg per day total dose
Divide into 8 mg twice daily or equivalent schedule
Parenteral equivalent when oral not feasible
IV dosing matching oral total daily dose
Transition to oral when able
Taper principles after definitive therapy
Gradual taper over days to weeks
Faster taper if rapid neurologic stability and short course
Adverse effect prevention
Gastric protection when high risk
Proton pump inhibitor or H2 blocker selection per local practice
Glucose monitoring and management
Insulin strategy when needed
Avoidance considerations
Strong infection concern requiring balancing risk
Severe uncontrolled diabetes requiring close monitoring
Definitive local control
Surgery and radiotherapy selection
Surgical decompression plus postoperative radiotherapy for selected patients
Single area of compression
Good performance status
Expected survival sufficient for recovery
Spinal instability needing fixation
Radioresistant tumor histology
Prior radiotherapy at level limiting re irradiation
Radiotherapy for non surgical candidates
Multiple level disease
Poor surgical candidacy
Limited expected survival
Radiosensitive histology
Emergency radiotherapy timing
Same day treatment for progressive deficit when not surgical
Coordination with immobilization and pain control
Radiotherapy dose fractionation concepts
Short course regimens for limited prognosis
Single fraction approaches
Hypofractionated courses
Longer course regimens for better prognosis
Multi fraction conventional courses
Improved local control emphasis
Stereotactic body radiotherapy considerations
Oligometastatic disease
Prior radiotherapy
Proximity to cord dose constraints
Analgesia and symptom control
Pain management
Opioids for severe pain
IV titration for acute severe pain
Reassess sedation and respiratory status
Non opioid adjuncts when appropriate
Acetaminophen for baseline pain
NSAID when renal function and bleeding risk acceptable
Neuropathic pain agents
Gabapentinoid consideration
Sedation monitoring
Bowel and bladder management
Urinary retention
Catheterization
Monitor for post obstructive diuresis
Constipation prophylaxis with opioids
Stimulant laxative
Add osmotic agent if needed
Anticoagulation and prophylaxis
Venous thromboembolism prevention
Mechanical prophylaxis when immobile
Intermittent pneumatic compression
Pharmacologic prophylaxis when safe
Hold or coordinate around urgent surgery or procedures
Special Populations
Pregnancy
Pregnancy specific considerations
Imaging approach
MRI without ionizing radiation preferred
Gadolinium risk benefit discussion when contrast considered
Steroid considerations
Dexamethasone maternal effects monitoring
Obstetric consultation for fetal monitoring when viable gestation
Radiotherapy considerations
Urgent maternal indication with fetal shielding planning
Multidisciplinary decision making
Geriatric
Older adult considerations
Baseline frailty and mobility
Higher fall risk during weakness
Rehab planning early
Steroid adverse effects risk
Delirium risk
Hyperglycemia risk
Myopathy risk
Surgical candidacy nuance
Bone quality affecting fixation
Higher perioperative risk assessment
Pediatrics
Pediatric considerations
Etiology differences
Neuroblastoma
Sarcoma
Leukemia or lymphoma
Imaging and sedation needs
MRI sedation pathway
Airway planning during sedation
Steroid dosing
Weight based dosing per pediatric oncology guidance
Growth and infection risk awareness
Background
Epidemiology
Epidemiologic features
Common oncologic emergency
Occurs in a minority of cancer patients
Often first presentation of malignancy in some cases
Most frequent primary tumors
Breast
Prostate
Lung
Myeloma
Typical anatomic distribution
Thoracic most common
Lumbar next most common
Cervical least common
Pathophysiology
Mechanisms of cord compromise
Epidural tumor extension from vertebral metastasis
Posterior vertebral body involvement
Epidural space invasion
Pathologic fracture with retropulsion
Bony fragment compression
Venous plexus spread
Multilevel seeding risk
Secondary edema and ischemia
Neurologic deficits partially steroid responsive
Therapeutic Considerations
Time dependence of neurologic recovery
Ambulatory status at treatment start predicts outcome
Longer duration of paralysis predicts poor recovery
Surgery plus radiotherapy benefits in selected patients
Improved ambulation likelihood
Improved continence likelihood
Improved local control
Radiotherapy effectiveness
Tumor cytoreduction and edema reduction
Better response in radiosensitive tumors
Steroid role
Reduces vasogenic edema
Provides analgesic benefit
Toxicity supports shortest effective course
Patient Discharge Instructions
Copy discharge instructions
Discharge instructions for patients not admitted
This condition can threaten walking and bladder or bowel control
Return immediately for new weakness in arms or legs
Return immediately for numbness in groin or inner thighs
Return immediately for trouble starting urination or inability to urinate
Return immediately for new loss of bladder or bowel control
Return immediately for worsening back pain especially at night
Avoid heavy lifting and high risk activities until cleared
Follow up plan
Oncology or hematology appointment date and time
Radiation oncology appointment date and time
Medication instructions
Steroid dosing schedule if prescribed
Do not stop steroids abruptly without guidance
Glucose checks if diabetic or prediabetic
Safety planning
Use assistive device if unsteady
Do not drive if leg weakness or sedating medications
References
Clinical Guidelines and consensus statements
Guideline sources
NICE guidance on spinal metastases and metastatic spinal cord compression
Imaging urgency and pathway recommendations
Steroid use recommendations
Oncology and radiation practice guidelines for metastatic spinal cord compression
Radiotherapy fractionation selection principles
Spine oncology surgical decision frameworks
SINS for instability risk
ESCC grading for epidural compression
Evidence Based Sources
Key trials and reviews
Randomized trial evidence supporting surgery plus radiotherapy in selected patients
Ambulation outcomes
Continence outcomes
Systematic reviews on corticosteroids in malignant spinal cord compression
Dose related toxicity considerations
Benefit in pain and neurologic symptoms
Reviews on radiotherapy approaches for metastatic spinal cord compression
Prognosis guided fractionation
Re irradiation and SBRT considerations
SymptomDx is an educational tool for medical professionals. It does not replace clinical judgment. Verify all clinical data and drug dosages with authoritative sources.